treat mild hearing loss emerging technology

Evidence of Emerging Technologies as a Treatment Option for Mild-to-Moderate Hearing Loss

by David Maidment, PhD In August 2017, President Trump signed into law the Food and Drug Administration (FDA) Reauthorization Act, which included the Over-the-Counter (OTC) Hearing Aid Act. The primary intention of the Act is to improve accessibility and affordability to hearing healthcare in adults with mild to moderate hearing loss. The FDA has one…

Read More

A Perfunctory Peep at the Economic Value of Direct-to-Consumer Hearing Devices

by Vinaya Manchaiah, PhD, and Amyn M Amlani, PhD   Most professionals are aware that the FDA Reauthorization Act of 2017 has been passed into law and, as a provision of this bill, the FDA is in the process of developing a category of over-the-counter (OTC) hearing aids for adults with mild-to-moderate hearing loss. Specifically,…

Read More